TONIX PHARMACEUTICALS HLDG C's ticker is TNXP and the CUSIP is 890260201. A total of 28 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $302,000 | -7.6% | 64,645 | -90.7% | 0.02% | +6.2% |
Q4 2016 | $327,000 | -61.8% | 696,455 | -43.3% | 0.02% | -59.0% |
Q3 2016 | $856,000 | -79.5% | 1,227,832 | -41.5% | 0.04% | -83.0% |
Q2 2016 | $4,174,000 | +11.9% | 2,097,248 | +35.5% | 0.23% | +12.2% |
Q1 2016 | $3,729,000 | -66.9% | 1,547,248 | +5.4% | 0.20% | -62.5% |
Q4 2015 | $11,258,000 | +77.9% | 1,467,858 | +22.7% | 0.55% | +79.3% |
Q3 2015 | $6,328,000 | -21.7% | 1,196,202 | +32.7% | 0.30% | -3.5% |
Q2 2015 | $8,084,000 | +45.2% | 901,202 | +2.3% | 0.32% | +33.9% |
Q1 2015 | $5,569,000 | +65.8% | 881,202 | +53.3% | 0.24% | +61.6% |
Q4 2014 | $3,358,000 | -5.9% | 575,000 | +9.5% | 0.15% | -8.8% |
Q3 2014 | $3,570,000 | -9.3% | 525,000 | +90.9% | 0.16% | +6.0% |
Q2 2014 | $3,938,000 | +37.7% | 275,000 | 0.0% | 0.15% | +3.4% |
Q1 2014 | $2,860,000 | – | 275,000 | – | 0.15% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,547,248 | $3,729,000 | 0.20% |
Broadfin Capital, LLC | 825,986 | $1,991,000 | 0.19% |
PURA VIDA INVESTMENTS, LLC | 159,877 | $385,000 | 0.18% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,315,551 | $3,170,000 | 0.14% |
FT Options LLC | 50,600 | $122,000 | 0.13% |
Lombard Odier Asset Management (USA) Corp | 231,974 | $559,000 | 0.08% |
SABBY MANAGEMENT, LLC | 385,248 | $928,000 | 0.05% |
Integre Asset Management, LLC | 57,501 | $139,000 | 0.04% |
BLUESTEIN R H & CO LLC | 185,975 | $448,000 | 0.03% |
Alambic Investment Management, L.P. | 33,880 | $82,000 | 0.03% |